Literature DB >> 6382680

Purification and amino acid composition of type A botulinum neurotoxin.

B R DasGupta, V Sathyamoorthy.   

Abstract

A method to purify type A botulinum neurotoxin from a 64 liter bacterial culture is reported. The procedure includes cation exchange chromatography at pH 7.0. The final product, essentially homogeneous (according to polyacrylamide gel-sodium dodecylsulfate electrophoresis), is a mixture of two forms of the neurotoxin (mol. wt 145,000); the dichain or nicked form (over 95%) and its precursor the single chain or unnicked form. Two batches of the neurotoxin purified by the method described here and one batch purified according to the method of Sugii and Sakaguchi were similar in purity and amino acid composition. The best estimate of the number of amino acid residues per neurotoxin molecule (mol. wt 145,000) is: Asp200Thr75Ser79Glu114Pro44Gly64Ala53Val70CyS10Met22Ile111Leu104Tyr71 Phe68Lys100His14Arg43Trp17.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6382680     DOI: 10.1016/0041-0101(84)90085-0

Source DB:  PubMed          Journal:  Toxicon        ISSN: 0041-0101            Impact factor:   3.033


  48 in total

1.  Structural analysis of botulinum neurotoxin types A and E in aqueous and nonpolar solvents by Fourier transform infrared, second derivative UV absorption, and circular dichroic spectroscopies.

Authors:  B R Singh; F M Wasacz; S Strand; R J Jakobsen; B R DasGupta
Journal:  J Protein Chem       Date:  1990-12

2.  The role of exoproteases in governing intraneuronal metabolism of botulinum toxin.

Authors:  Lance L Simpson; Andrew B Maksymowych; Hirokazu Kouguchi; Garrett Dubois; Roop S Bora; Suresh Joshi
Journal:  Protein J       Date:  2005-04       Impact factor: 2.371

3.  Botulinum neurotoxin types A, B, and E: fragmentations by autoproteolysis and other mechanisms including by O-phenanthroline-dithiothreitol, and association of the dinucleotides NAD(+)/NADH with the heavy chain of the three neurotoxins.

Authors:  Bibhuti R Dasgupta; Babu S Antharavally; William Tepp; Mary L Evenson
Journal:  Protein J       Date:  2005-08       Impact factor: 2.371

4.  Clostridium botulinum types A, B, C1, and E produce proteins with or without hemagglutinating activity: do they share common amino acid sequences and genes?

Authors:  E Somers; B R DasGupta
Journal:  J Protein Chem       Date:  1991-08

Review 5.  Toxigenic clostridia.

Authors:  C L Hatheway
Journal:  Clin Microbiol Rev       Date:  1990-01       Impact factor: 26.132

6.  Pure botulinum neurotoxin is absorbed from the stomach and small intestine and produces peripheral neuromuscular blockade.

Authors:  A B Maksymowych; M Reinhard; C J Malizio; M C Goodnough; E A Johnson; L L Simpson
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

7.  Purification, modeling, and analysis of botulinum neurotoxin subtype A5 (BoNT/A5) from Clostridium botulinum strain A661222.

Authors:  Mark J Jacobson; Guangyun Lin; William Tepp; Jerome Dupuy; Pål Stenmark; Raymond C Stevens; Eric A Johnson
Journal:  Appl Environ Microbiol       Date:  2011-04-22       Impact factor: 4.792

8.  Antibody mapping to domains of botulinum neurotoxin serotype A in the complexed and uncomplexed forms.

Authors:  F Chen; G M Kuziemko; P Amersdorfer; C Wong; J D Marks; R C Stevens
Journal:  Infect Immun       Date:  1997-05       Impact factor: 3.441

9.  Sensitive enzyme-linked immunosorbent assay for detection of Clostridium botulinum neurotoxins A, B, and E using signal amplification via enzyme-linked coagulation assay.

Authors:  G J Doellgast; M X Triscott; G A Beard; J D Bottoms; T Cheng; B H Roh; M G Roman; P A Hall; J E Brown
Journal:  J Clin Microbiol       Date:  1993-09       Impact factor: 5.948

10.  Biomaterials in urinary incontinence and treatment of their complications.

Authors:  Philippa Sangster; Roland Morley
Journal:  Indian J Urol       Date:  2010-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.